St. Louis, MO, 7 April 2009 - Elsevier, the leading global publisher of scientific, technical and medical information products and services, announced today the acquisition of the assets of Professional Development Software, Inc. (PDS), the provider of 
Softwarefornurses.com online learning education products. PDS will be integrated into Elsevier’s Evolve Testing and Remediation product suite (which includes the ‘HESI Test’), bringing additional content to Elsevier’s total curriculum solution for nursing.
“PDS products are current, well-written, and very useful to nursing students and faculty seeking a review and remediation resource in preparing for the NCLEX®,” said Sebastian Vos, Elsevier’s Vice President for eLearning. “It is a perfect fit within the Evolve Testing and Remediation product suite.”
For schools of nursing, PDS Software for Nurses modules are used for learning reinforcement, guidance in decision making, remediation, clinical make up and NCLEX® review. For healthcare organizations, the modules are used for orientation, competency testing, cross training, remediation, and continuing education.
PDS customers can continue to visit
www.softwarefornurses.com for product information and any updates related to joining the
Evolve Testing and Remediation product suite. The suite comprises some of the best possible test preparation tools in the industry for both students and teachers, and is run by Elsevier, the world’s leading and largest provider of medical content, tools and services. Terms of the agreement are not being disclosed.
###
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as
ScienceDirect,
MD Consult,
Scopus, bibliographic databases, and online reference works.
Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact:
Tom Reller
Elsevier
+1 212 462 1912
t.reller@elsevier.com
